Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants

Two chemoattractants for human monocytes were purified to apparent homogeneity from the culture supernatant of a glioma cell line (U- 105MG) by sequential chromatography on Orange A-Sepharose, an HPLC cation exchanger, and a reverse phase HPLC column. On SDS-PAGE gels under reducing or nonreducing conditions, the molecular masses of the two peptides glioma-derived chemotactic factor 1 and 2 were 15 and 13 kD, respectively. Amino acid composition of these molecules was almost identical, and differed from other cytokines that have been reported. The NH2 terminus of each peptide was apparently blocked. When tested for chemotactic efficacy, the peptides attracted approximately 30% of the monocytes added to chemotaxis chambers, at the optimal concentration of 10(-9) M. Potency and efficacy were comparable with that of FMLP, which is often used as a reference attractant. The activity was chemotactic rather than chemokinetic. In contrast to their interaction with human monocytes, the pure peptides did not attract neutrophils. These pure tumor-derived chemoattractants can now be compared with attractants produced by normal cells and evaluated for their biological significance in human neoplastic disease.

[1]  J. Pontén,et al.  Long term culture of normal and neoplastic human glia. , 2009, Acta pathologica et microbiologica Scandinavica.

[2]  E. Appella,et al.  Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. , 1989, Journal of immunology.

[3]  J. Kuratsu,et al.  Production and characterization of human glioma cell-derived monocyte chemotactic factor. , 1989, Journal of the National Cancer Institute.

[4]  J. Shabanowitz,et al.  Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  E. Appella,et al.  Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.

[6]  A. Mantovani,et al.  Induction of monocyte migration by recombinant macrophage colony-stimulating factor. , 1988, Journal of immunology.

[7]  R. Derynck,et al.  Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin. , 1988, The EMBO journal.

[8]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Mantovani,et al.  Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice. , 1987, Journal of immunology.

[10]  P. Allavena,et al.  Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. , 1987, Immunology.

[11]  A. Mantovani,et al.  Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. , 1987, Journal of immunology.

[12]  A. Mantovani,et al.  Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants. , 1986, Journal of immunology.

[13]  I. Fidler Macrophages and metastasis--a biological approach to cancer therapy. , 1985, Cancer research.

[14]  A. Mantovani,et al.  Tumor‐derived chemotactic factor(S) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues , 1985, International journal of cancer.

[15]  A. J. Valente,et al.  Initial characterization of a peripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. , 1984, The American journal of pathology.

[16]  N. de Tribolet,et al.  Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. , 1984, Journal of immunology.

[17]  C. Heldin,et al.  A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Luger,et al.  Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. , 1983, Journal of immunology.

[19]  A. Mantovani,et al.  Regulation of the macrophage content of neoplasms by chemoattractants. , 1983, Science.

[20]  A. Mantovani,et al.  Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: Evidence for a role in the regulation of the macrophage content of neoplastic tissues , 1983, International journal of cancer.

[21]  E. Leonard,et al.  Effects of cell concentration on chemotactic responsiveness of mouse resident peritoneal macrophages. , 1981, Journal of the Reticuloendothelial Society.

[22]  W. Falk,et al.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. , 1980, Journal of immunological methods.

[23]  M. Meltzer,et al.  Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions. , 1978, Journal of immunology.

[24]  M. Meltzer,et al.  Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors. , 1977, Cancer research.

[25]  B. Mackler,et al.  Physicochemical characterization of chemotatic lymphokines produced by human T and B lymphocytes. , 1975, Journal of immunology.

[26]  R. Snyderman,et al.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. , 1972, Journal of immunology.

[27]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[28]  P. Ward,et al.  The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. , 1970, Cellular immunology.

[29]  B. Zbar,et al.  Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism. , 1970, Journal of the National Cancer Institute.

[30]  S. Haskill,et al.  Activities of macrophages within and peripheral to the tumor mass. , 1983 .

[31]  D. B. Amos,et al.  THE MACROPHAGE AS A TUMORICIDAL EFFECTOR CELL: A REVIEW OF IN VIVO AND IN VITRO STUDIES ON THE MECHANISM OF THE ACTIVATED MACROPHAGE NONSPECIFIC CYTOTOXIC REACTION * , 1976 .